PAIN SYNDROME IN OSTEOPOROSIS TREATMENT

Objective: to evaluate the clinical efficacy and safety of Amelotex (the international non-proprietary name of meloxicam) in patients with osteoarthrosis (OA) and recurrent synovitis. Subjects and methods. The open randomized study included 40 patients with knee-joint OA of predominantly X-ray stage...

Full description

Saved in:
Bibliographic Details
Main Author: N A Khitrov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2009-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/225
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040710106972160
author N A Khitrov
author_facet N A Khitrov
author_sort N A Khitrov
collection DOAJ
description Objective: to evaluate the clinical efficacy and safety of Amelotex (the international non-proprietary name of meloxicam) in patients with osteoarthrosis (OA) and recurrent synovitis. Subjects and methods. The open randomized study included 40 patients with knee-joint OA of predominantly X-ray stages II and III, who were found to have synovitis. A study group comprised 20 patients receiving Amelotex and a control group consisted of 20 patients taking diclofenac. Amelotex was intramuscularly injected in a dose of 1,5 ml once daily for 5 days; diclofelac was intramuscularly used in a dose of 3 ml in the same regimen. No other treatment was performed during therapy with both Amelotex and diclofenac. Results. The use of 5-day therapy with intramuscular Amelotex in gonarthrosis patients has demonstrated its symptom-modifying action that is reflected by reductions in the pain syndrome and swelling of the joint, an increase in the volume of its movements, and a lower WOMAC index, which is comparable with that in the treatment with diclofenac. Conclusion. The results of the study suggest the good tolerability of Amelotex and its clinical efficacy in patients with OA.
format Article
id doaj-art-179a622e4fdc4f80a32208ec080c598a
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2009-06-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-179a622e4fdc4f80a32208ec080c598a2025-08-20T02:56:01ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2009-06-0132485210.14412/1996-7012-2009-5401530PAIN SYNDROME IN OSTEOPOROSIS TREATMENTN A KhitrovObjective: to evaluate the clinical efficacy and safety of Amelotex (the international non-proprietary name of meloxicam) in patients with osteoarthrosis (OA) and recurrent synovitis. Subjects and methods. The open randomized study included 40 patients with knee-joint OA of predominantly X-ray stages II and III, who were found to have synovitis. A study group comprised 20 patients receiving Amelotex and a control group consisted of 20 patients taking diclofenac. Amelotex was intramuscularly injected in a dose of 1,5 ml once daily for 5 days; diclofelac was intramuscularly used in a dose of 3 ml in the same regimen. No other treatment was performed during therapy with both Amelotex and diclofenac. Results. The use of 5-day therapy with intramuscular Amelotex in gonarthrosis patients has demonstrated its symptom-modifying action that is reflected by reductions in the pain syndrome and swelling of the joint, an increase in the volume of its movements, and a lower WOMAC index, which is comparable with that in the treatment with diclofenac. Conclusion. The results of the study suggest the good tolerability of Amelotex and its clinical efficacy in patients with OA.https://mrj.ima-press.net/mrj/article/view/225osteoarthrosissynovitisamelotex
spellingShingle N A Khitrov
PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
Современная ревматология
osteoarthrosis
synovitis
amelotex
title PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
title_full PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
title_fullStr PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
title_full_unstemmed PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
title_short PAIN SYNDROME IN OSTEOPOROSIS TREATMENT
title_sort pain syndrome in osteoporosis treatment
topic osteoarthrosis
synovitis
amelotex
url https://mrj.ima-press.net/mrj/article/view/225
work_keys_str_mv AT nakhitrov painsyndromeinosteoporosistreatment